Leopardlike PET Pattern and Sarcoidlike Reaction - Report - MDSpire
Advertisement
Leopardlike PET Pattern and Sarcoidlike Reaction
A rare but often favorable immune-related adverse event associated with immune checkpoint inhibitors can mimic cancer progression on imaging and typically resolves with conservative management.
Clinical Report: Leopardlike PET Pattern and Sarcoidlike Reaction
Overview
A distinctive leopardlike pattern of hypermetabolic muscle lesions on PET/CT led to the diagnosis of a drug-induced sarcoidosislike reaction in a patient undergoing immune checkpoint inhibitor therapy. This finding highlights the importance of biopsy to differentiate between sarcoidosislike reactions and true tumor progression.
Background
Sarcoidosislike reactions (SLRs) are increasingly recognized immune-related adverse events associated with immune checkpoint inhibitors, which can mimic malignancy on imaging. Accurate diagnosis is crucial as SLRs may indicate favorable outcomes and tumor control rather than disease progression. Understanding these reactions can guide appropriate management and avoid unnecessary treatment discontinuation.
Data Highlights
No numerical data available in the source material.
Key Findings
['A 52-year-old woman developed a leopardlike pattern of hypermetabolic lesions after 9 months of durvalumab therapy.', 'Muscle and skin biopsies confirmed a drug-induced sarcoidosislike reaction, not cancer progression.', 'SLRs occur in approximately 4% of patients treated with immune checkpoint inhibitors, with up to 50% being asymptomatic.', '65% to 88% of patients with SLR experience tumor response or stable disease.', 'More than 90% of lesions improve or resolve, regardless of corticosteroid use.', 'Clinical symptoms and imaging abnormalities resolved completely within 3 months without systemic corticosteroids in the reported case.']
Clinical Implications
Clinicians should consider the possibility of sarcoidosislike reactions in patients receiving immune checkpoint inhibitors who present with new hypermetabolic lesions. Biopsy is essential to differentiate these reactions from true tumor progression, which can inform management decisions and potentially avoid unnecessary treatment interruptions.
Conclusion
Sarcoidosislike reactions induced by immunotherapy are rare but generally associated with favorable outcomes. Accurate diagnosis through biopsy is critical for guiding appropriate clinical management.
